Budesonide/formoterol effects on metalloproteolytic balance in TGFβ-activated human lung fibroblasts
- 1 November 2009
- journal article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 103 (11), 1755-1763
- https://doi.org/10.1016/j.rmed.2009.03.018
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroidsBritish Journal of Pharmacology, 2008
- Airway remodelling in asthma: Current understanding and implications for future therapiesPharmacology & Therapeutics, 2006
- Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthmaThorax, 2005
- Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPDEuropean Respiratory Journal, 2004
- Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEuropean Respiratory Journal, 2002
- Proteomics — the protein expression technology to study connective tissue biologyJournal of Pharmaceutical and Biomedical Analysis, 2001
- Matrix Metalloproteinases and Tissue lnhibitors of Matrix Metalloproteinases in Sputum from Patients with Bronchial AsthmaJournal of Asthma, 2001
- MATRIX PROTEOGLYCANS: From Molecular Design to Cellular FunctionAnnual Review of Biochemistry, 1998
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993
- Proliferation of cultured fibroblasts is inhibited byL‐Iduronate—containing glycosaminoglycansJournal of Cellular Physiology, 1991